Top Ten 2023: Research-Related Developments to Watch
- March 10, 2023
Based on AHLA’s annual Health Law Connections article, this special series brings together thought leaders from across the health law field to discuss the top ten issues of 2023. In the tenth episode, Tynan Kugler, Principal, PYA, speaks with Rebecca Schaefer, Partner, K&L Gates LLP, about research-related policy initiatives and regulatory changes to watch. They discuss the FDA’s September 2022 Noticed of Proposed Rulemaking, Biden Administration initiatives including the Cancer Moonshot and investment in cancer-focused clinical trial networks, the efforts of the newly formed Advanced Research Projects Agency for Health, and developments related to Presidential Memo 33 on research security. Sponsored by PYA.
You must be logged in to access this content.